自動注射器の市場規模、シェア、動向分析：製品別、適応症別、最終用途別、地域別、セグメント予測、2025年～2030年

自動注射器市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の自動注射器市場規模は2025～2030年にかけて15.1%のCAGRを記録し、2030年には206億米ドルに達すると予測されています。

アナフィラキシーショックや糖尿病、リウマチ、多発性硬化症などの疾病の発生率の上昇が、自動注射器の承認の増加とともに成長を促しています。

生命を脅かすアレルギーの有病率の増加とこれらのデバイスの需要の増加は、成長を助けると予想されます。食物アレルギーの調査・教育によると、毎年約20万人がアレルギー性食物反応のために緊急医療を必要としています。

さらに、承認の増加が成長を促進すると予想されます。例えば、2018年8月、米国FDAは、アナフィラキシーを含む緊急アレルギー反応を治療するためのTeva Pharmaceuticalsの最初のジェネリックエピネフリン自動注射器を承認しました。それぞれ0.15mgのエピペンJrと0.3mgのエピペンのジェネリック医薬品は、体重33ポンド以上の小児と成人患者に適応されます。

さらに、メーカー各社も新製品や革新的技術の開発を進めており、市場の成長を促進すると期待されています。例えば、2018年6月、アッヴィ合同会社は、ロック機能＆注入開始・終了アラートだけでなく、検査窓を備え、10秒で完全に注入する完全ヒト型抗腫瘍壊死因子αモノクローナル抗体製剤「ヒュミラ」を発売しました。これらのデバイスは、患者の受容性とコンプライアンスに従って設計されているため、需要が増加しています。技術の進歩により、より便利で使いやすいものになると予想されます。このことは、患者が慢性疾患にこの技術を採用することを後押ししています。

自動注射器市場レポートハイライト

• 使い捨て自動注射器セグメントは2024年に56.8%の最大市場シェアを占め、予測期間中最も速いCAGRが期待されます。再利用可能な自動注射器セグメントは、利便性と費用対効果に対する患者の嗜好の高まりに牽引され、著しい成長を遂げています。
• 糖尿病セグメントは2024年に28.9％の最大市場シェアを占めました。多発性硬化症（MS）セグメントは、予測期間中に最も速い成長を示すと予想されています。
• 在宅ケアセグメントは、2024年に54.1％と最大の収益シェアを占め、予測期間中に最も速い成長が見込まれます。病院クリニックセグメントも予測期間中に大きな成長が見込まれます。
• 北米の自動注射器市場は世界市場全体を支配し、2024年には45.3％の収益シェアを占めました。米国の自動注射器市場は、2024年に北米の自動注射器産業で大きなシェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 自動注射器市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 自動注射器市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 自動注射器市場：製品別、推定・動向分析

• セグメントダッシュボード
• 自動注射器市場：製品変動分析
• 製品別自動注射器市場展望
• 2018～2030年の市場規模と予測と動向分析
• 使い捨て自動注射器
• 再利用可能な自動注射器

第5章 自動注射器市場：適応症別、推定・動向分析

• セグメントダッシュボード
• 自動注射器市場：適応症変動分析
• 適応症別自動注射器市場展望
• 2018～2030年の市場規模と予測と動向分析
• 関節リウマチ
• 多発性硬化症
• 糖尿病
• アナフィラキシー
• その他

第6章 自動注射器市場：最終用途別、推定・動向分析

• セグメントダッシュボード
• 自動注射器市場：最終用途変動分析
• 最終用途別自動注射器市場展望
• 2018～2030年の市場規模と予測と動向分析
• 在宅ケア
• 病院とクリニック
• 外来手術センター

第7章 自動注射器市場：地域別、推定・動向分析

• 地域ダッシュボード
• 地域別自動注射器市場変動分析
• 自動注射器市場：製品、適応症、最終用途による地域推定・動向分析
• 2018～2030年の市場規模と予測と動向分析
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 企業市場シェア分析、2024年
• 主要企業プロファイル
  • Eli Lilly
  • SHL Medical AG
  • AbbVie, Inc.
  • Amgen
  • Owen Mumford
  • Ypsomed
  • Teva Pharmaceutical
  • Biogen Idec
  • Mylan NV
  • Pfizer, Inc.
  • Sanofi
  • Gerresheimer AG

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 4 Global auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 5 Global auto-injectors market, by end use 2018 - 2030 (USD Million)
• Table 6 North America auto-injectors market, by region, 2018 - 2030 (USD Million)
• Table 7 North America auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 8 North America auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 9 North America auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 11 U.S. auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 12 U.S. auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 14 Canada auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 15 Canada auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 17 Mexico auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 18 Mexico auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe auto-injectors market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 21 Europe auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 22 Europe auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 23 UK auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 24 UK auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 25 UK auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 26 Germany auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 27 Germany auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 28 Germany auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 29 France auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 30 France auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 31 France auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 33 Italy auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 34 Italy auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 36 Spain auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 37 Spain auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 38 Norway auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 39 Norway auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 40 Norway auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 41 Sweden auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 42 Sweden auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 43 Sweden auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 44 Denmark auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 45 Denmark auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 46 Denmark auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific auto-injectors market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 51 Japan auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 52 Japan auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 53 Japan auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 54 China auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 55 China auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 56 China auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 57 India auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 58 India auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 59 India auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 60 Australia auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 61 Australia auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 62 Australia auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 63 South Korea auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 64 South Korea auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 65 South Korea auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 67 Thailand auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 68 Thailand auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America auto-injectors market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 71 Latin America auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 72 Latin America auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 74 Brazil auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 75 Brazil auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 77 Argentina auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 78 Argentina auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa auto-injectors market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 83 South Africa auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 84 South Africa auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 85 South Africa auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 89 UAE auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 90 UAE auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 91 UAE auto-injectors market, by end use, 2018 - 2030 (USD Million)
• Table 92 Kuwait auto-injectors market, by product, 2018 - 2030 (USD Million)
• Table 93 Kuwait auto-injectors market, by indication, 2018 - 2030 (USD Million)
• Table 94 Kuwait auto-injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Auto-Injectors market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Auto-injectors market, type outlook key takeaways (USD Million)
• Fig. 12 Auto-injectors market type movement analysis (USD Million), 2024 & 2030
• Fig. 13 Disposable auto-injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Reusable auto-injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Prefilled market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Empty market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17 Auto-injectors market, indication outlook key takeaways (USD Million)
• Fig. 18 Auto-injectors market indication movement analysis (USD Million), 2024 & 2030
• Fig. 19 Rheumatoid arthritis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 20 Multiple sclerosis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Anaphylaxis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Other therapies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Auto-injectors market, end use outlook key takeaways (USD Million)
• Fig. 25 Auto-injectors market end use movement analysis (USD Million), 2024 & 2030
• Fig. 26 Homecare settings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 27 Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Auto-injectors market: Regional key takeaways (USD Million)
• Fig. 30 Auto-injectors market regional outlook, 2024 & 2030, USD Million
• Fig. 31 North America auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 32 U.S. auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Canada auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Mexico auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Europe auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 UK auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Germany auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 France auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Spain auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Italy auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Sweden auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Norway auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Denmark auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Asia Pacific auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 China auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Japan auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 India auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 South Korea auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Australia auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Thailand auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Latin America auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Brazil auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Argentina auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Middle East and Africa auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 South Africa auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 UAE auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 List of key emerging company's/indication disruptors/innovators

Autoinjectors Market Growth & Trends:

The global autoinjectors market size is expected to reach USD 20.6 billion by 2030, registering a CAGR of 15.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidence of anaphylactic shock and other diseases such as diabetes, rheumatoid, & multiple sclerosis along with increasing approvals of auto-injectors are impelling growth.

Increasing prevalence of life-threatening allergies and rising demand for these devices are expected to aid growth. As per the Food Allergy Research & Education, around 200, 000 people every year need emergency medical care for allergic food reactions.

In addition, increasing approvals are anticipated to drive growth. For instance, in August 2018, U.S. FDA approved the first generic epinephrine auto-injector of Teva Pharmaceuticals to treat emergency allergic reactions, including anaphylaxis. Generic versions of EpiPen Jr & EpiPen of 0.15 mg & 0.3 mg, respectively, are indicated for pediatric and adult patients weighing more than 33 pounds.

Moreover, manufacturers are also developing new products and innovative technologies, which is expected to propel market growth. For instance, in June 2018, AbbVie GK launched Humira, which is a fully human antitumor necrosis factor alpha monoclonal antibody formulation with lock function & injection start & end alerts as well as an inspection window and injects completely in 10 seconds. Demand for these devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are anticipated to make them more convenient and user-friendly. This is encouraging patients to adopt this technology for chronic illnesses.

Autoinjectors Market Report Highlights:

• The disposable autoinjectors segment accounted for the largest market share of 56.8% in 2024 and is expected to witness the fastest CAGR over the forecast period. The reusable auto injector segment is witnessing significant growth, driven by increasing patient preference for convenience and cost-effectiveness.
• The diabetes segment accounted for the largest market share of 28.9% in 2024. The multiple sclerosis (MS) segment is expected to witness the fastest growth over the forecast period.
• The homecare settings segment accounted for the largest revenue share of 54.1% in 2024 and is expected to witness the fastest growth over the forecast period. The hospitals and clinics segment is also expected to witness significant growth over the forecast period.
• The North America autoinjectors market dominated the overall global market and accounted for the 45.3% revenue share in 2024. The autoinjectors market in the U.S. held a significant share of North America's auto-injectors industry in 2024.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Product
  • 1.1.2. Indication
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Indication outlook
  • 2.2.3. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Auto-Injectors Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of targeted therapies
    • 3.2.1.2. Increase in the incidence of anaphylactic shock
    • 3.2.1.3. Patients' preference to choose self-administration of injections
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Availability of its substitute products like general injections and oral tablets
• 3.3. Auto-Injectors Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Auto-Injectors Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Auto-Injectors Market: Product Movement Analysis
• 4.3. Auto-Injectors Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Disposable Auto-Injectors
  • 4.5.1. Disposable Auto-Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Reusable Auto-Injectors
  • 4.6.1. Reusable Auto-Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.1.1. Prefilled Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.6.1.1.1. Prefilled Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.1.2. Empty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.6.1.2.1. Empty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Auto-Injectors Market: Indication Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Auto-Injectors Market: Indication Movement Analysis
• 5.3. Auto-Injectors Market by Indication Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Rheumatoid Arthritis
  • 5.5.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Multiple Sclerosis
  • 5.6.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Diabetes
  • 5.7.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Anaphylaxis
  • 5.8.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Other Therapies
  • 5.9.1. Other Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Auto-Injectors Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Auto-Injectors Market: End Use Movement Analysis
• 6.3. Auto-Injectors Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Homecare Settings
  • 6.5.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Hospitals & Clinics
  • 6.6.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Ambulatory Surgical Centers
  • 6.7.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Auto-Injectors Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Auto-Injectors Market movement analysis
• 7.3. Auto-Injectors Market: Regional Estimates & Trend Analysis by Product, Indication & End Use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Germany Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. France Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Italy Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Spain Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Denmark Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Sweden Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Norway Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. India Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Australia Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Thailand Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Brazil Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. South Africa Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Saudi Arabia Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. UAE Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement scenario
    • 7.9.5.5. Kuwait Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Company Market Share Analysis, 2024
• 8.3. Key Company Profiles
  • 8.3.1. Eli Lilly
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Product benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. SHL Medical AG
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Product benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. AbbVie, Inc.
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Product benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Amgen
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Owen Mumford
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Ypsomed
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Teva Pharmaceutical
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Biogen Idec
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Mylan N.V.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Pfizer, Inc.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. Sanofi
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Gerresheimer AG
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives